GLP-2 analog teduglutide significantly reduces need for parenteral nutrition and stool frequency in...
GLP-2 analog teduglutide significantly reduces need for parenteral nutrition and stool frequency in a real-life setting
About this item
Full title
Author / Creator
Publisher
London, England: SAGE Publications
Journal title
Language
English
Formats
Publication information
Publisher
London, England: SAGE Publications
Subjects
More information
Scope and Contents
Contents
Background:
To evaluate the benefits of teduglutide in a real-life setting, we analyzed the data of 14 patients with short bowel syndrome treated with teduglutide. Additionally, we studied glucagon-like peptide 2 (GLP-2) receptor expression in samples of small intestinal and colonic tissue to provide explanations for clinical observations.
Me...
Alternative Titles
Full title
GLP-2 analog teduglutide significantly reduces need for parenteral nutrition and stool frequency in a real-life setting
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_449e672a0ee74b119649b46da966f762
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_449e672a0ee74b119649b46da966f762
Other Identifiers
ISSN
1756-2848,1756-283X
E-ISSN
1756-2848
DOI
10.1177/1756284818793343
